Pasithea Therapeutics Corp.

KTTA | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.51

-$0.01 (-2.62%)

At close: Sep 21, 2026, 4:00 PM ET

$0.51

$0 (+0.16%)

After-hours: Sep 21, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-20.43B	-13.9M	-15.51M	-11.73M	-2.17M	-40.98K
Depreciation & Amortization	32.42M	649.03K	648.45K	5.09K	1.38K	n/a
Stock-Based Compensation	297.47M	773.69K	592.27K	835.06K	471.25K	n/a
Other Working Capital	-318.58K	-1.52M	1.57M	845.35K	-329.44K	2.3K
Other Non-Cash Items	4.89B	77.81K	-732.57K	-3.65M	750K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.33M	n/a
Change in Working Capital	-318.58K	-1.52M	1.57M	845.35K	111.23K	2.3K
Operating Cash Flow	-15.21B	-13.92M	-13.43M	-13.69M	-3.17M	-38.69K
Capital Expenditures	n/a	-2	-34.3K	-107.1K	-21.5K	-1
Cash Acquisitions	n/a	n/a	n/a	-2.19M	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	11M	n/a	433.31K	-626.9K	n/a	n/a
Investing Cash Flow	11M	n/a	399.01K	-2.93M	-21.5K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-3.73M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	63.45B	n/a	n/a	-3.21M	5.69M	n/a
Financial Cash Flow	63.52B	4.52M	-3.73M	-3.21M	55.93M	282.34K
Net Cash Flow	48.34B	-9.41M	-16.76M	-19.88M	52.72M	243.65K
Free Cash Flow	-15.21B	-13.92M	-13.46M	-13.8M	-3.2M	-38.69K
Adj. Free Cash Flow	-15.51B	-14.7M	-14.05M	-14.63M	-3.67M	-38.69K
Maintenance CapEx	n/a	-2	-34.3K	-107.1K	-1.38K	n/a
Growth CapEx	n/a	n/a	n/a	n/a	-20.12K	-1
Owner Earnings	-15.21B	-13.92M	-13.46M	-13.8M	-3.18M	-38.69K